期刊文献+

低剂量激素替代疗法对绝经后妇女血清同型半胱氨酸水平的影响

The Effect of Lower Doses Hormone Replacement Therapy on Homocysteine Serum Level in Postmenopausal Women
在线阅读 下载PDF
导出
摘要 目的观察低剂量激素替代疗法(HRT)治疗后绝经后妇女血清同型半胱氨酸(Hcy)的变化及其对心血管系统的影响。方法选取本院围绝经期门诊62例绝经后妇女作为研究对象,30例已接受HRT治疗2~6年者为长期治疗组;另32例从未接受HRT者为未治疗组,其中22例随后完成6个月的HRT治疗,为短期治疗组,另10例不用HRT者为对照组。长期治疗组、未治疗组同时抽取肘静脉血,测定空腹血清Hcy水平;短期治疗组接受HRT6个月后、对照组6个月后再测定空腹血清Hcy水平。结果血清Hcy水平长期治疗组为(10.1±2.2)μmol/L,未治疗组为(11.50±2.70)μmol/L,两组比较,差异显著(P<0.05)。短期治疗组治疗后Hcy水平较治疗前下降(0.81±0.25)μmol/L,用药前后差异显著(P<0.05);对照组6个月前后Hcy水平差别为(0.47±1.30)μmol/L,无明显变化(P<0.05)。结论HRT可降低绝经后妇女血清Hcy水平。 Objective To observe the effect of hormone replacement therapy (HRT) on fasting total homocysteine serum level in postmenopausal women. Methods 62 postmenopausal women were recruited.30 women who have taken HRT for 2-6 years served as long -term treatment group, and another 32 women who never took HRT served as non-treatment group. In non-treatment group, 22 women who took HRT for 6 months served as short-term treatment group, and another 10 women served as the control group. Fasting total homocysteine serum level was determined in long-term treatment group and non-treatment group. Measurement of fasting total homocysteine serum level was performed after 6 months in short-term treatment group and control group. Results Compared with non-treatment group, women of long-term treatment group had statistically lower homocysteine serum level, (10.10±2.20)μmol/L vs (11.80±2.70)μmol/L(P<0.05). Homocysteine serum level decreased by (0.81±0.25)μmol/L after 6 months of treatment using HRT in short-term treatment group, and the decrease was significant (P<0.05).But change of homocysteine serum level was not significant(P>0.05) in control group. Conclusion HRT may decrease homocysteine serum level in postmenopausal women.
出处 《白求恩军医学院学报》 2005年第2期77-79,共3页 Journal of Bethune Military Medical College
关键词 激素替代疗法 同型半胱氨酸 绝经后妇女 Hormone replacement therapy Homocysteine Postmenopausal women
  • 相关文献

参考文献14

  • 1[1]Grady D,Herringtin D,Bitter V,et al.Cardiovascular disease during 6-8 years of hormone therapy.Heart and Estrogen/progestin Replacement study follow-up (HERS Ⅱ).JAMA,2002,288(1):58-66.
  • 2[2]Imitroma KR,Degroot K,Myers AK,et al.Estrogen and homocysteine.Cadiovascular Research,2002,53(2):577-588.
  • 3[3]Joseph J,Joseph L,Shekhawat NS,et al.Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats.Circ Physiol Heart Physiol,2003,285(2):679-686
  • 4[4]Kalra DK.Homocysteine and cardiovascular disease.Curr Atheroscler Rep,2004,6(2):101-106.
  • 5[5]Olsewski AJ,McCully KS.Homocysteine content of lipoprotein in hypercholesterolemia.Atherosclerosis,1991,88(1):61-68.
  • 6[6]Brown CA,Mckinney KQ,Yang KB,et al.The C677T metylenetrahydrofolate reductase polymorphism influences the homocysteine-lowring effect of hormone replacement therapy.Mol Gene Metab,1999,67(1):43-48.
  • 7[7]Marchesoni D,Plaino L,Villani MT,et al.Menopause rather than estrogen modifies plasma homocysteine levels.In Obstet Gynecol,2003,81(2):293-297.
  • 8[8]Smolders GV,van der Mooren MJ,Teerlink T,et al.A randomized placebo-controlled study of the effect of transdermal vs.oral estradiol with or without gestodene on homcysteine levels.Fertil steril,2003,79(2):261-266.
  • 9[9]Nygard O,Vollset SE,Refsum H,et al.Total plasma homocysteine and cardiovascular risk profile.The Hordaland Study.J Am Med Assos,1995,274(19):1526-1533.
  • 10[10]Morris MS,Jacques PF,Selhub J,et al.Total homocysteine and estrogen status indicators in the third national health and nutrition examination survey.Am J Epidemiol,2000,152(2):140-148.

二级参考文献8

  • 1Mijatovic V,Kenemans P,Netelenbos C,et al.Postmenopausal oral 17beta-estradiol continuously combined with dydrogesterone reduces fasting serum homobcysteine levels[].Fertility and Sterility.1998
  • 2Sheyr J,Malthora A,Schaible TF,et al.Effects of gonadectomy and hormonal replacement on rat hearts[].Circulation Research.1987
  • 3Pines A,Fisman EZ,Levo Y,et al.The effects of hormone replacement therapy in normal postmenopausal women: measurements of Dopplerderived parameters of aortic flow[].American Journal of Obstetrics and Gynecology.1991
  • 4Voutilainen S,Hippelainen M,Hulkko S,et al.Left ventricular diastolic function by doppler echocardiography in relation to hormonal replacement therapy in healthy postmenopausal women[].The American Journal of Cardiology.1993
  • 5Aarsand AK,Carlsen SM.Folate administration reduces circulating homocysteine levels in NIDDM patients on long-term metformin treatment[].Journal of Internal Medicine.1998
  • 6van der Mooren MJ,Wouters MGAJ,Blom HJ.Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women[].European Journal of Clinical Investigation.1994
  • 7Mijatovic V,Kenemans P,Netelenbos C,et al.A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women[].Obstetrics and Gynecology.1998
  • 8van Baal WM,Smolders RG,van der Mooren MJ,et al.Hormone replacement therapy and plasma homocysteine levels[].Obstetrics and Gynecology.1999

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部